HomeCompareSURRY vs JNJ

SURRY vs JNJ: Dividend Comparison 2026

SURRY yields 16.00% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SURRY wins by $866.51M in total portfolio value
10 years
SURRY
SURRY
● Live price
16.00%
Share price
$1.90
Annual div
$0.30
5Y div CAGR
60.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$866.54M
Annual income
$783,243,046.55
Full SURRY calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — SURRY vs JNJ

📍 SURRY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSURRYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SURRY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SURRY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SURRY
Annual income on $10K today (after 15% tax)
$1,360.36/yr
After 10yr DRIP, annual income (after tax)
$665,756,589.57/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, SURRY beats the other by $665,752,552.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SURRY + JNJ for your $10,000?

SURRY: 50%JNJ: 50%
100% JNJ50/50100% SURRY
Portfolio after 10yr
$433.29M
Annual income
$391,623,898.21/yr
Blended yield
90.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SURRY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
7.8
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SURRY buys
0
JNJ buys
0
No recent congressional trades found for SURRY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSURRYJNJ
Forward yield16.00%2.14%
Annual dividend / share$0.30$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR60.8%28%
Portfolio after 10y$866.54M$30.5K
Annual income after 10y$783,243,046.55$4,749.88
Total dividends collected$860.20M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: SURRY vs JNJ ($10,000, DRIP)

YearSURRY PortfolioSURRY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,273$2,573.48$10,594$274.49+$2.7KSURRY
2$19,336$5,133.43$11,294$360.69+$8.0KSURRY
3$31,928$11,238.09$12,133$476.91+$19.8KSURRY
4$62,049$27,886.51$13,156$635.42+$48.9KSURRY
5$147,838$81,445.09$14,432$854.61+$133.4KSURRY
6$449,806$291,619.55$16,056$1,162.76+$433.8KSURRY
7$1,814,688$1,333,395.43$18,175$1,604.53+$1.80MSURRY
8$10,025,934$8,084,218.66$21,009$2,252.68+$10.00MSURRY
9$77,849,504$67,121,753.69$24,911$3,229.73+$77.82MSURRY
10$866,542,015$783,243,046.55$30,458$4,749.88+$866.51MSURRY

SURRY vs JNJ: Complete Analysis 2026

SURRYStock

Sun Art Retail Group Limited, an investment holding company, operates brick-and-mortar stores and online sales channels in the People's Republic of China. It operates hypermarkets, superstores, and mini stores under RT-Mart, RT-Super, and RT-Mini names. As of March 31, 2022, it had a total of 490 hypermarkets, nine superstores, and 103 mini stores. The company also provides consulting, investment, wholesaling, and retailing services. Sun Art Retail Group Limited was founded in 1998 and is based in Shanghai, the People's Republic of China.

Full SURRY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SURRY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SURRY vs SCHDSURRY vs JEPISURRY vs OSURRY vs KOSURRY vs MAINSURRY vs ABBVSURRY vs MRKSURRY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.